The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement: Comorbidity and Outcomes After Hip Replacement

  title={The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement: Comorbidity and Outcomes After Hip Replacement},
  author={Sheldon Greenfield and Giovanni Apolone and Barbara J. McNeil and Paul D. Cleary},
  journal={Medical Care},
Co-existent or comorbid diseases are appreciated as prognostic factors in studies of quality and effectiveness of care when mortality is the end point. The need to measure and adjust for comorbidity in studies of postoperative hospital complications or long-term recovery from surgery has not been documented. In this study, we determined the impact of co-existent disease on post-operative complications and 1-year health-related quality of life in patients hospitalized for a total hip replacement… 
The effect of comorbidities on health-related quality of life in patients placed on the waiting list for total joint replacement
Background: Co-morbidity is a powerful predictor of health care outcomes and costs, as well as an important cofounder in epidemiologic studies. The effect of co-morbidities is generally related to
Postoperative Medical Complications and Intermediate Care Unit/Intensive Care Unit Admission in Joint Replacement Surgery: A Prospective Risk Model.
The introduced risk-estimation model offers a specialized preoperative resource-stratification method in knee joint replacement surgery and condenses the most influential, individual risk factors to avoid clinical test redundancy and improve resource efficiency and presurgical care planning.
Does Co-morbidity provide significant improvement on age adjustment when predicting medical outcomes?
The predictive performance of co-morbidity derived from electronic hospital data is outcome and risk-adjustment method specific.
Relationship between the Volume of Total Hip Replacements Performed by Providers and the Rates of Postoperative Complications in the State of Washington*
There was a significant relationship between surgeons who averaged fewer than two hip replacements annually (low-volume surgeons) and a worse outcome, and hospital charges were inversely related to hospital volume, even after adjustment for patient-related factors.
Association of hospital resource use with comorbidity status and patient age among hip fracture patients in Japan.
The results suggest that the presence of comorbidity among operable hip fracture patients requires greater resource use during their hospital stay, but higher age is not significantly associated with greater resources use at all.
Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide in-patient sample database
Effective control of comorbidity in breast cancer patients may reduce post-operative morbidity and mortality and reduce in-hospital outcomes among women with breast cancer after surgery.
Using patient reports to assess health-related quality of life after total hip replacement
The data indicate substantial benefits from hip arthroplasty, and pre-surgical functioning was a strong predictor of outcomes 1 year after surgery.
Waiting for total hip arthroplasty: avoidable loss in quality time and preventable deterioration.
Although there was no direct effect of waiting time on postoperative outcomes, patients in a later phase of the disease process did not improve to the level achieved by patients with better preoperative function.
Incidence and short-term outcomes of primary and revision hip replacement in the United States.
Perioperative complications, readmissions, and the association between these outcomes and certain patient and hospital variables were analyzed and it was found advanced age, comorbidities, and nonelective admissions are associated with inferior outcomes.
Comorbidity as a correlate of length of stay for hospitalized patients with acute chest pain
In this population of patients with acute chest pain, comorbidity as measured with the Charlson index was independently associated with length of stay after adjustment for other clinical data.